AstraZeneca vaccine: Blood clots are “extremely rare” and benefits outweigh risks, regulators conclude

E Mahase - 2021 - bmj.com
AstraZeneca vaccine: Blood clots are “extremely rare” and benefits outweigh risks, regulators
conclude | The BMJ Skip to main content Intended for healthcare professionals Access …

ABO blood group and link to COVID-19: A comprehensive review of the reported associations and their possible underlying mechanisms

E Pereira, S Felipe, R de Freitas, V Araújo… - Microbial …, 2022 - Elsevier
ABO blood group is long known to be an influencing factor for the susceptibility to infectious
diseases, and many studies have been describing associations between ABO blood types …

Inflammatory mediators of platelet activation: focus on atherosclerosis and COVID-19

P Theofilis, M Sagris, AS Antonopoulos… - International Journal of …, 2021 - mdpi.com
Background: Atherosclerotic cardiovascular diseases are characterized by a dysregulated
inflammatory and thrombotic state, leading to devastating complications with increased …

Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis

M Zuin, S Barco, G Giannakoulas, MM Engelen… - Journal of Thrombosis …, 2023 - Springer
Data regarding the occurrence of venous thromboembolic events (VTE), including acute
pulmonary embolism (PE) and deep vein thrombosis (DVT) in recovered COVID-19 patients …

Extracellular vesicles and thrombosis: update on the clinical and experimental evidence

K Zifkos, C Dubois, K Schäfer - International Journal of Molecular …, 2021 - mdpi.com
Extracellular vesicles (EVs) compose a heterogenous group of membrane-derived particles,
including exosomes, microvesicles and apoptotic bodies, which are released into the …

Post-COVID Syndrome in Adults—An Overview

RE Scharf, JM Anaya - Viruses, 2023 - mdpi.com
This article provides an overview of various aspects related to post-COVID syndrome. Apart
from its prevalence, symptoms and sequelae, risk determinants, and psychosocial …

Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis

V Mai, BK Tan, S Mainbourg, F Potus, M Cucherat… - Vascular …, 2021 - Elsevier
Background Many studies confirmed an association between COVID-19 and venous
thromboembolism (VTE). Whether the risk of VTE significantly differed between COVID-19 …

Pulmonary circulation abnormalities in post-acute COVID-19 syndrome: dual-energy CT angiographic findings in 79 patients

I Mohamed, V de Broucker, A Duhamel, J Giordano… - European …, 2023 - Springer
Objectives To evaluate the frequency and pattern of pulmonary vascular abnormalities in the
year following COVID-19. Methods The study population included 79 patients remaining …

COVID-19, vaccines, and thrombotic events: a narrative review

MG Abrignani, A Murrone, L De Luca, L Roncon… - Journal of clinical …, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19), a deadly pandemic that has affected millions of
people worldwide, is associated with cardiovascular complications, including venous and …

Signaling through FcγRIIA and the C5a-C5aR pathway mediate platelet hyperactivation in COVID-19

SA Apostolidis, A Sarkar, HM Giannini… - Frontiers in …, 2022 - frontiersin.org
Patients with COVID-19 present with a wide variety of clinical manifestations.
Thromboembolic events constitute a significant cause of morbidity and mortality in patients …